Search Videos and More
News
Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective therapies, we bring hope to patients with serious and debilitating lung diseases.
Course
Pleural Effusions and Pleural Disease
Pleural disease is a common but frequently misunderstood clinical entity within the field of pulmonary disease. While up to 30% of individuals assessed may have pleural effusions, the specific diagnostic and therapeutic modalities undertaken have significant downstream implications for the diagnostic yield of studies, potential complication profile, and in the setting of therapeutic procedures, the extent to which these can either help to facilitate overall treatment or to reduce symptom burden in the case of palliative-type procedures such as tunneled pleural catheters or chemical pleurodesis for malignant pleural effusions.
News
Update for Providers: Temple Healthy Chest Initiative’s Dual Screening Referral Process
News
Advanced Bronchoscopic Services
As the only integrated pulmonary and critical care medicine, sleep medicine, and thoracic surgery department in the nation, the highly experienced, multidisciplinary team at the Temple Lung Center is consistently setting new standards of care in bronchoscopic research, technology, treatment, and recovery. Temple offers an enhanced patient experience with a single centralized location for both treatment and recovery.
News
2024 Lung Transplant Symposium: Surgical and Medical Insights for Transplant Assessment and Management
Presented by Temple cardiothoracic surgery and pulmonary faculty as a pre-conference activity at the January 2024 STS Annual Meeting, this symposium, “Surgical and Medical Insights for Transplant Assessment and Management” will provide insight to best practice approach for surgical and medical care of lung transplant patients.
News
Lung Transplant Program Referral Information
The Temple Lung Transplant Program is a leader in both quantity and quality. It’s the nation’s highest volume program, but it also has the best one-year survival rates in Philadelphia and all of Pennsylvania.
News
Optimizing Treatment for CTD-ILD
When autoimmune or connective tissue diseases cause inflammation or scarring of the lungs, both diagnosis and effective management can be challenging.
Course
Diagnosis and Treatment of Obesity-Hypoventilation Syndrome
Obesity hypoventilation syndrome (OHS) is a respiratory disorder resulting in multisystem dysfunction. This program will review the epidemiology, pathophysiology, and mortality of this disorder. Current treatment recommendations as put forth by the American Thoracic Society Assembly on Sleep and Respiratory Neurobiology will be presented, including a comprehensible treatment algorithm.
Video
Bronchoscopic Lung Volume Reduction in Patients with Advanced Emphysema
As part of the Pulmonology On Air 2022 Global Event, Gerard Criner, MD, FACP, FACCP, Director of the Temple Lung Center, demonstrates a LIVE endobronchial valve placement on a patient with advanced homogenous emphysema.
News
Advanced COPD Fact Sheet
As the nation’s leading COPD research and treatment center, Temple sets new standards for COPD care.
Course
COVID Pneumonia
"COVID pneumonia represents the active inflammation of the pulmonary parenchyma that is caused by SARS-CoV-2, the coronavirus that has caused the COVID-19 pandemic. Millions of patients have been affected worldwide and hospitalizations have occurred all over the globe. The condition can range from mild to severe and represents a challenge for clinicians. Despite the above there is still significant morbidity and mortality associated with COVID pneumonia. It is important for clinicians to recognize this entity, and follow closely the rapidly changing recommendations regarding management and treatment."
Course
Recognizing and Treating Tracheobronchomalacia
"Tracheobronchomalacia (TBM) is an under-recognized cause of shortness of breath, recurrent respiratory infections and chronic coughing. It involves collapse of the main airways, due to a weakness of the cartilage and/or floppiness of the posterior membranous wall. The activity will inform physicians and advanced practitioners about the importance of a multidisciplinary approach in the management of TBM, from diagnosis to treatment. We emphasize the need of reserving surgery to severely symptomatic patients who fail medical therapy, and the importance of objective long-term follow-up of this challenging condition."